Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Crystallized carbohydrate spheres for slow release and targeting.

U Schröder

    Methods in Enzymology
    |January 1, 1985
    PubMed
    Summary

    New crystallized carbohydrate spheres offer a versatile drug delivery system. These spheres effectively encapsulate bioactive substances, ensuring their activity upon release and enabling targeted delivery for enhanced therapeutic outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    How standardization of the pre-analytical phase of both research and diagnostic biomaterials can increase reproducibility of biomedical research and diagnostics.

    New biotechnology·2019
    Same author

    [MEDCARE for People in Eritrea : A report on 9 years' help through self-help].

    HNO·2019
    Same author

    Revealing metabolic storage processes in electrode respiring bacteria by differential electrochemical mass spectrometry.

    Bioelectrochemistry (Amsterdam, Netherlands)·2018
    Same author

    HNO·2017
    Same author

    [Cricohyoidopexy (CHP) and Cricohyoidoepiglottopexy (CHEP). Indication, complications, functional und oncological results].

    HNO·2017
    Same author

    Second-line treatment of recurrent HNSCC: tumor debulking in combination with high-dose-rate brachytherapy and a simultaneous cetuximab-paclitaxel protocol.

    Radiation oncology (London, England)·2016

    Area of Science:

    • Biomaterials Science
    • Drug Delivery Systems
    • Carbohydrate Chemistry

    Background:

    • Biologically active substances like insulin, interferon, and growth hormone require stable matrices for effective delivery.
    • Existing drug delivery systems face challenges with maintaining biological activity and achieving targeted release.
    • Low-toxicity carbohydrate-based materials are sought for pharmaceutical and medical applications.

    Purpose of the Study:

    • To develop and characterize novel crystallized carbohydrate spheres (CCS) as a matrix for entrapping and releasing bioactive substances.
    • To evaluate the potential of CCS for immunization strategies, particularly with weak antigens, by incorporating immunomodulators.
    • To explore the magnetic targeting capabilities of CCS by co-entrapping magnetite particles for localized drug delivery.

    Main Methods:

    • Preparation of CCS using a scalable high-pressure homogenization technique.
    • Entrapment of biologically active substances (e.g., insulin, interferon, growth hormone) and antigens with co-entrapped immunomodulators.
    • Co-entrapment of magnetite particles to create magnetically responsive microspheres.
    • Analysis of substance release mechanisms, focusing on matrix erosion and stability under physiological conditions (pH, ionic strength).

    Main Results:

    • The developed CCS effectively entrap and release bioactive substances while preserving their biological activity.
    • CCS demonstrate potential as an adjuvant in immunization, likely due to slow release and macrophage stimulation from small sphere size.
    • Magnetically responsive CCS can be targeted to specific body areas, such as the brain, for enhanced drug concentration.
    • The preparation method is highly scalable, allowing for large-scale daily production of CCS.
    • Substance release occurs via matrix erosion, producing non-modified degradation products, and is not influenced by enzymatic degradation.

    Conclusions:

    • Crystallized carbohydrate spheres represent a promising, low-toxicity matrix for controlled and targeted delivery of therapeutic agents.
    • The CCS technology offers a scalable and effective platform for drug delivery, immunization, and magnetic targeting applications.
    • The inherent stability of the carbohydrate matrix in physiological conditions ensures predictable release profiles without enzymatic interference.

    Related Experiment Videos